NAFLD, FLI, and ALT significantly mediated the baPWV-metabolic syndrome association, accounting for 18.4, 6.6, and 4.2 of the proportion, respectively. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.